Most Recent
A court has rejected an objection by J&J to a registration notice in a class action over cold medication that flags the applicant’s opposition to soft class closure.
Alphapharm has agreed it won't supply a generic version of HIV drug Odefsey while a dispute with Gilead over three patents for the drug is on foot.
A shareholder class action alleges Cochlear knew months before announcing a profit downgrade that weakening US demand, financial pressures on hospitals and problems with its new Nexa implant made its FY26 earnings guidance unreliable.
Hearing implant giant Cochlear faces a second shareholder class action following two forecast downgrades that wiped billions of dollars from the company's market value.
Hearing implant manufacturer Cochlear has been hit with a shareholder class action alleging its FY26 profit forecast failed to disclose challenges in its business.
Pfizer has lost a patent infringement lawsuit against Samsung Bioepis over the generic version of its blockbuster autoimmune drug Enbrel, with a judge finding all but one of the patent's claims is invalid.
The maker of Maltofer iron supplements is suing Arrotex over ads that claim its Ferro-grad C iron supplement is faster acting and reduces the risk of constipation.
A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.
A judge has suggested there may be merit in waiting for Johnson & Johnson to file a defence before deciding an application for a group costs order in a class action accusing the company of selling defective, carcinogenic talcum powder.
Former West Coast Eagles player Daniel Venables' case against two doctors and a neurologist has been struck out, with a judge finding he had failed to adequately plead a negligence case.